Myocardial infarction
Conditions
Brief summary
The composite of cardiac death, spontaneous myocardial infarction or definite or probable stent thrombosis within 3 months.
Detailed description
Time to the following outcomes at 3- and 12 months (unless specified): Bleeding Academic Research Consortium (BARC) types 3 or 5 bleeding (time-to-event), Definite or probable stent thrombosis or spontaneous target vessel myocardial infarction (time-to-event), Any spontaneous myocardial infarction (time-to-event), All-cause mortality (time-to-event), The composite of cardiac death, spontaneous target vessel myocardial infarction or definite or probable stent thrombosis within 12 months., Platelet reactivity as assessed by the ADP-test (multiplate), at 24 hours and 3 months.
Interventions
Sponsors
Vaestra Goetalandsregionen, Vaestra Goetalandsregionen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The composite of cardiac death, spontaneous myocardial infarction or definite or probable stent thrombosis within 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to the following outcomes at 3- and 12 months (unless specified): Bleeding Academic Research Consortium (BARC) types 3 or 5 bleeding (time-to-event), Definite or probable stent thrombosis or spontaneous target vessel myocardial infarction (time-to-event), Any spontaneous myocardial infarction (time-to-event), All-cause mortality (time-to-event), The composite of cardiac death, spontaneous target vessel myocardial infarction or definite or probable stent thrombosis within 12 months., Platelet reactivity as assessed by the ADP-test (multiplate), at 24 hours and 3 months. | — |
Countries
Sweden
Outcome results
None listed